Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Capital Expenditures (2019 - 2025)

Historic Capital Expenditures for AdaptHealth (AHCO) over the last 7 years, with Q3 2025 value amounting to $94.2 million.

  • AdaptHealth's Capital Expenditures rose 5824.1% to $94.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $355.8 million, marking a year-over-year increase of 1211.91%. This contributed to the annual value of $306.1 million for FY2024, which is 930.71% down from last year.
  • According to the latest figures from Q3 2025, AdaptHealth's Capital Expenditures is $94.2 million, which was up 5824.1% from $88.7 million recorded in Q2 2025.
  • AdaptHealth's Capital Expenditures' 5-year high stood at $142.9 million during Q4 2022, with a 5-year trough of $35.6 million in Q1 2021.
  • Its 5-year average for Capital Expenditures is $79.8 million, with a median of $81.3 million in 2024.
  • Per our database at Business Quant, AdaptHealth's Capital Expenditures skyrocketed by 131244.76% in 2021 and then plummeted by 3797.09% in 2023.
  • Over the past 5 years, AdaptHealth's Capital Expenditures (Quarter) stood at $63.6 million in 2021, then soared by 124.63% to $142.9 million in 2022, then tumbled by 37.97% to $88.6 million in 2023, then dropped by 12.76% to $77.3 million in 2024, then grew by 21.86% to $94.2 million in 2025.
  • Its Capital Expenditures was $94.2 million in Q3 2025, compared to $88.7 million in Q2 2025 and $95.6 million in Q1 2025.